通过衰老细胞调节瘤可塑性:解读基本机制和生存途径,以解开治疗选择
Andrew Oliveira Silva1,2, Thais Cardoso Bitencourt2,3, Jose Eduardo Vargas4
1Faculdade Estácio, Porto Alegre, RS, Brazil.
Genetics and molecular biology
|May 28, 2024
概括
细胞衰老,一种不可逆转的增长停止状态,可以矛盾地促进癌症的进展. 瘤中的衰老细胞释放的因素增强了癌症的可塑性和对治疗的抵抗力.
科学领域:
- 细胞生物学 细胞生物学
- 癌症生物学 癌症生物学
- 在瘤学瘤学.
背景情况:
- 衰老是一种不可逆转的细胞循环停止的状态.
- 复制性衰老限制了细胞分裂,而诱导衰老可以由DNA损伤或压力引发.
- 瘤细胞经常绕过衰老,以实现癌症的标志性特征,即不朽.
研究的目的:
- 审查衰老细胞 (SnCs) 如何促进癌症可塑性.
- 讨论SnC抵抗细胞死亡的机制.
- 探索针对SnCs的治疗策略.
主要方法:
- 关于衰老和癌症可塑性的文献综述.
- 对驱动SnC相关分泌表现型 (SASP) 的分子机制的分析.
- 讨论癌症中衰老细胞的治疗向.
主要成果:
- 衰老细胞,特别是通过SASP,可以促进癌症的可塑性.
- SASP促进了诸如细胞分化,干性,重编程和上皮-介质酶过渡等过程.
- 衰老细胞表现出对细胞死亡的抵抗力,使治疗方法复杂化.
结论:
- 瘤中衰老细胞的积累可以推动瘤的进展.
- 准衰老细胞及其SASP是一种有前途的治疗途径.
- 需要进一步的研究,以解决针对癌症治疗的衰老的开放问题和临床观点.
相关概念视频
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


